Evaluation of 23 cutaneous anthrax patients in eastern Anatolia, Turkey: Diagnosis and risk factors

International Journal of Dermatology

Volumn 47, Issue 10, 2008, Pages 1033-1037

  Ozcan, Hamdi ^a   Kayabas, Uner ^a   Bayindir, Yasar ^a   Bayraktar, Mehmet R ^a   Ay, Selma ^a  

^a INONU UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CIPROFLOXACIN; CLINDAMYCIN; CORTICOSTEROID; MEROPENEM; PENICILLIN G; PENICILLIN G POTASSIUM; PREDNISOLONE; PROCAINE PENICILLIN; VANCOMYCIN;

ADOLESCENT; ADULT; ANGIONEUROTIC EDEMA; ANTHRAX; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL SKIN DISEASE; BACTERIUM CULTURE; CLINICAL ARTICLE; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; FOOD CONTAMINATION; GRAM POSITIVE BACTERIUM; GRAM STAINING; HUMAN; INSECT BITE; MALE; MICROBIOLOGICAL EXAMINATION; RISK FACTOR; SCHOOL CHILD; SEPTIC SHOCK; TURKEY (REPUBLIC); ZOONOSIS;

ADOLESCENT; ADULT; ANIMAL DISEASES; ANIMALS; ANTHRAX; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CHILD; DIAGNOSTIC ERRORS; EDEMA; ERYTHEMA; FATIGUE; FEMALE; FEVER; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; RISK FACTORS; SKIN DISEASES, BACTERIAL; TURKEY; YOUNG ADULT; ZOONOSES;

EID: 54749154146     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2008.03665.x     Document Type: Article

References (20)

1. Sternbach G. The history of anthrax. J Emerg Med 2003; 24: 463-467.
2. Demirdag K, Ozden M, Saral Y, et al. Cutaneous anthrax in adults: A review of 25 cases in the eastern Anatolian region of Turkey. Infection 2003; 31: 327-330.
3. Irmak H, Buzgan T, Karahocagil MK, et al. Cutaneous manifestations of anthrax in Eastern Anatolia: A review of 39 cases. Acta Med Okayama 2003; 57: 235-240.
4. Carucci JA, McGovern TW, Norton SA, et al. Cutaneous anthrax management algorithm. J Am Acad Dermatol 2002; 47: 766-769.
5. Cieslak TJ, Eitzen EM Jr. Clinical and epidemiologic principles of anthrax. Emerg Infect Dis 1999; 5: 552-555.
6. Hugh-Jones M. 1996-97 Global Anthrax Report. J Appl Microbiol 1999; 87: 189-191.
7. Schmid G, Kaufmann A. Anthrax in Europe: Its epidemiology, clinical characteristics, and role in bioterrorism. Clin Microbiol Infect 2002; 8: 479-488.
8. Inglesby TV, O'Toole T, Henderson DA, et al. Anthrax as a biological weapon 2002: Updated recommendations for management. J Am Med Assoc 2002; 287: 2236-2252.
9. Kaya A, Tasyaran MA, Erol S, et al. Anthrax in adults and children: A review of 132 cases in Turkey. Eur J Clin Microbiol Infect Dis 2002; 21: 258-261.
10. Doganay M, Kökkaya A, Hah MM. 35 Şarbon olgusunun dèerlendirimi. Microbiol Bült 1983; 17: 1-10.
11. Swartz MN. Recognition and management of anthrax: An update. N Engl J Med 2001; 345: 1621-1626.
12. Oncul O, Ozsoy MF, Gul HC, et al. Cutaneous anthrax in Turkey: A review of 32 cases. Scand J Infect Dis 2002; 34: 413-416.
13. Tatti KM, Greer P, White E, et al. Morphologic, immunologic, and molecular methods to detect Bacillus anthracis in formalin-fixed tissues. Appl Immunohistochem Mol Morph 2006; 14: 234-243.
14. Shlyakhov E, Rubinstein E. Evaluation of the anthraxin skin test for diagnosis of acute and past human anthrax. Eur J Clin Microbiol Infect Dis 1996; 15: 242-245.
15. Godyn JJ, Reyes L, Siderits R, Hazra A. Cutaneous anthrax: Conservative or surgical treatment? Adv Skin Wound Care 2005; 18: 146-150.
16. Doganay M. Anthrax. In: Cohen J, Powderly WG, eds. Infectious Diseases, 2nd edn. Edinburgh: Mosby, 2004: 1685-1689.
17. Esel D, Doganay M, Sumerkan B. Antimicrobial susceptibilities of 40 isolates of Bacillus anthracis isolated in Turkey. Int J Antimicrob Agents 2003; 22: 70-72.
18. Bakici MZ, Elaldi N, Bakir M, et al. Antimicrobial susceptibility of Bacillus anthracis in an endemic area. Scand J Infect Dis 2002; 34: 564-566.
19. Caca I, Cakmak SS, Unlu K, et al. Cutaneous anthrax on eyelids. Jpn J Ophthalmol 2004; 48: 268-271.
20. Gurcan S, Akata F, Kuloglu F, et al. Meningitis due to Bacillus anthracis. Yonsei Med J 2005; 46: 159-160.